Work with us to optimize our existing biomarkers for use in your clinical trials

Integrate our biomarkers into your clinical trials for patient selection and efficacy assessment

Enhance your chances of successful treatment development and approval

Increase treatment rates in the real world, with our clinically available biomarkers

Brainomix AI-powered biomarkers and products provide real value across the entire lifesciences ecosystem
Research and Clinical Trials
                                    Partner with us to use our biomarkers in collaborations and in prospective clinical trials
Assess therapeutic efficacy, optimize cohort selection and compare early stage treatments
Plan your studies with us, using novel biomarkers to guide study designs
Execute your research with biomarkers available in
the real world for patient identification and
monitoring

                                
Clinical Care
                                    Identify the right treatments for the right patients by using our biomarkers in your clinical workflow
Monitor your patients with our biomarkers to inform your treatment selection and patient monitoring
Reduce radiology burden with our automated solutions
Standardize the care in your center with our zero
variability analysis

                                

Contact Us Today

Speak with us to learn how we can support your clinical development, research and projects with our innovative solutions and biomarkers.

*Mandatory field

I have read the Brainomix privacy policy

I would like to receive information about products or services from Brainomix

Hear from our valued partners and collaborators

"The Brainomix AI-based image analysis technology can allow us to accelerate the development of lung cancer treatments that are much needed"

Prof. Florian Gantner, Head of Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim.

"Brainomix's history of establishing successful collaborations, and their expertise in AI imaging biomarkers, certainly brings positive momentum to OSIC."

Elizabeth Estes, OSIC Executive Director.

Brainomix is an example of the UK’s world-leading strengths in life sciences and AI-enabled medtech, combining expertise in clinical care and software development with more than 150 years’ experience in the field across its leadership team."

Alastair Kilgour, Parkwalk Advisors, London, UK.

"Brainomix has proven its ability to deliver scalable AI-imaging solutions that have demonstrated tremendous value to patients worldwide."

Dr Oliver Reuss, Boehringer Ingelheim Venture Fund (BIVF).